RFS
LGND icon

Richardson Financial Services’s Ligand Pharmaceuticals LGND Stock Holding History

Richardson Financial Services’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47.5K Buy
238
+10
+4% +$1.98K 0.03% 304
2025
Q4 		$43.1K Buy
228
+18
+9% +$3.46K 0.01% 314
2025
Q3 		$37.2K Buy
210
+97
+86% +$14.4K 0.02% 311
2025
Q2 		$12.7K Buy
113
+36
+47% +$3.85K 0.01% 379
2025
Q1 		$8.1K Hold
77
– – 0.01% 407
2024
Q4 		$8.14K Buy
+77
New +$8.7K 0.01% 426

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Richardson Financial Services's LGND Position: Q1 2026 in Review

Richardson Financial Services increased its Ligand Pharmaceuticals (LGND) stake by 4.4% in Q1 2026, buying an estimated $1.98K and bringing the position to 238 shares worth $47.5K. The position accounts for 0.03% of the portfolio, ranked #304.

Richardson Financial Services first reported a position in LGND in Q4 2024 and has held it in 6 quarters since. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Richardson Financial Services held 238 shares of Ligand Pharmaceuticals worth $47.5K as of Q1 2026.
  • Richardson Financial Services bought 10 Ligand Pharmaceuticals shares in Q1 2026, an estimated $1.98K.
  • Ligand Pharmaceuticals made up 0.03% of Richardson Financial Services's portfolio in Q1 2026, its #304 holding.
  • Richardson Financial Services first reported a position in Ligand Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Richardson Financial Services's 13F filing for Q1 2026, filed 4 May 2026.